TD Cowen flags star-rating risk for CVS Health stock

Published on 10/14/2026 at 12:42 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

TD Cowen sees 70.00 percent of 2027 members in four-star plans. CVS Health stock costs EUR 78.55 on October 14, 2026, 0.81 percent above the Xetra close.

Three dated signals for CVS

TD Cowen said 70.00 percent of members were in four-star plans for 2027 on October 9, 2026.
Second-quarter 2026 revenue reached USD 106.10 billion, up 7.30 percent year over year.
CVS Health stock trades at EUR 78.55 at 12:38 p.m. CEST at Lang & Schwarz on October 14, 2026, 0.81 percent above the Xetra close of October 13, 2026.

Moderner Apothekenverkaufsraum mit Apothekerin und Kundin vor Medikamentenregalen — CVS Health Corp. zeigt fotorealen Apothekenverkaufsraum mit Apothekerin und Kundin, ISIN US1266501006, Illustration mit AI erstellt.

CVS Health Corp. (ISIN US1266501006) was trading at EUR 78.55 at Lang & Schwarz on October 14, 2026, at 12:38 p.m. CEST, 0.81 percent above the Xetra close of October 13, 2026 at EUR 77.92. On October 9, 2026, Investing.com reported that TD Cowen expected 70.00 percent of CVS Health's Medicare Advantage enrollment to be in four-star plans for 2027, down from 82.00 percent in 2026.

CVS Health events since May

On May 6, 2026, CVS Health reported first-quarter 2026 revenue of USD 100.40 billion, up 6.20 percent year over year, according to Ticker Scout. On August 5, 2026, second-quarter 2026 revenue rose 7.30 percent year over year to USD 106.10 billion, while adjusted earnings per share reached USD 2.58 versus USD 1.81 a year earlier, the same filing summary said. On October 9, 2026, TD Cowen's Medicare Advantage assessment supplied the latest dated operating signal.

What does the star-rating risk mean?

The pressure is concentrated in quality-linked Medicare Advantage economics. Investing.com reported that the share of members in plans rated at least 4.50 stars could fall to 35.00 percent in 2027 from 63.00 percent in 2026. TD Cowen estimated an unmitigated USD 720.00 million headwind in 2028, equivalent to USD 0.41 in adjusted earnings per share and 5.00 percent of adjusted earnings-per-share growth.

Upcoming dates and distributions

MarketBeat lists October 22, 2026 as the record date for CVS Health's USD 0.6650 dividend. Ticker Scout places the expected filing of the next Form 10-Q around October 28, 2026.

Stock trades above the Xetra close

CVS Health stock was trading at EUR 78.55 at Lang & Schwarz on October 14, 2026, at 12:38 p.m. CEST, 0.81 percent or EUR 0.63 above the Xetra close of October 13, 2026 at EUR 77.92. The stock's primary listing is on the NYSE, where CVS Health's 52-week range was USD 69.51 to USD 110.68 in the October 11, 2026 market data cited by MarketBeat. The further course of trading is shown by the continuously updated real-time quote of CVS Health stock.